BioProcess Insider - News BioProcess International

Podcast: Biopharma’s evolving relationships with CDMOs

M&A, new modalities, and COVID-19 have all changed the way drug sponsors work with their third-party manufacturers, according to delegates from Samsung Biologics, Catalent, and AGC Biologics. The BioProcess Insider Expression Platform (BIEP) podcast is back, with an in-depth look at the evolv ...

Maturing gene therapy pipelines driving Catalent growth and expansion
As pharma’s gene therapy pipeline matures, Catalent plans to invest more in the sector to meet high viral vector demand and advance growth. ...
Pfizer pledges to pull out of Russian manufacturing pacts
Pfizer says it is ceasing all future investment to build manufacturing capacity in Russia due to Vladimir Putin’s war against Ukraine. Putin ...
PE firm Astorg to buy CordenPharma from ICIG
Astorg Partners has signed an agreement with International Chemical Investors Group (ICIG) to acquire CDMO CordenPharma. According to French ...
Repligen: Robust bioprocess market will offset reduced COVID demand
Repligen has tweaked its guidance in the wake of diminishing COVID-related orders but remains positive going forward due to a “very strong orde ...

Covering the whole development process for the global biotechnology industry

More From BioProcess Insider

Recent Tweets